COMPARE · Data as of August 21, 2026

DOC vs OHI

Verdict: Side-by-side breakdown using the Bull Rankings model. DOC scored 69.0, OHI scored 72.0 — OHI leads.
Compare another set
DOC
Healthpeak Properties, Inc.
REIT - Healthcare Facilities · Financial strength
67.5Fin
$21.33 · $15.1B
fundamentals as of
Strength gap
6.9
OHI leads
OHI
Omega Healthcare Investors, Inc.
REIT - Healthcare Facilities · Financial strength
74.4Fin
$46.61 · $14.9B
fundamentals as of
  • Fastest growthOHI+13.2%
  • Strongest balance sheetOHI0.71
THE BULL RANKINGS SCORECARD67.5/ 100 · FIN STRENGTHPEER MEDIANREIT67.5
THE BULL RANKINGS SCORECARD74.4/ 100 · FIN STRENGTHPEER MEDIANREIT74.4
YieldDOC5.9%OHI5.8%
RevDOC+4.5%OHI+13.2%
D/EDOC1.09OHI0.71
DOC
OHI
5.9%A-
Yield
5.8%A-
+4.5%C+
Rev
+13.2%B+
1.09B
D/E
0.71B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
DOCHealthpeak Properties, Inc.
REIT - Healthcare Facilities · $21.33 · beta 1.00
Why now
REIT - Healthcare Facilities · market cap $15.1b. 7% off the 52-week high of $22.95. 19 sell-side analysts rate this a Buy with a mean 1-yr target of $22.87 (implying +7% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 349% of earnings on a 5.9% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
OHIOmega Healthcare Investors, Inc.
REIT - Healthcare Facilities · $46.61 · beta 0.58
Why now
REIT - Healthcare Facilities · market cap $14.9b. 11% off the 52-week high of $52.39. Revenue growing +13%, comfortably above the S&P median. 18 sell-side analysts rate this a Buy with a mean 1-yr target of $51.94 (implying +11% upside).
Moat
Net margin 68% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Dividend payout 95% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 11.8x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.